Caricamento...

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

The prognosis of patients with cancer remains poor in spite of the advances obtained in recent years with new therapeutic agents, new approaches in surgical procedures and new diagnostic methods. The discovery of a plethora of cellular targets and the rational generation of selective targeting agent...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Teresa Troiani, Erika Martinelli, Floriana Morgillo, Anna Capasso, Anna Nappi, Vincenzo Sforza, Fortunato Ciardiello
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publishing 2013-01-01
Serie:Therapeutic Advances in Medical Oncology
Accesso online:https://doi.org/10.1177/1758834012462462
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !